Report Detail
Global Malaria Vaccines Market Insights, Forecast to 2025
- RnM3487485 |
- 04 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Malaria Vaccines are used for malaria treatment.Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.
The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market.
The global Malaria Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Malaria Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Malaria Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Malaria Vaccines in these regions.
This research report categorizes the global Malaria Vaccines market by top players/brands, region, type and end user. This report also studies the global Malaria Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
Market size by Product
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine
Market size by End User
Hospitals
Clinics
Community Centers
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Malaria Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Malaria Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Malaria Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Malaria Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Malaria Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Malaria Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Malaria Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Malaria Vaccines Market Size Growth Rate by Product
- 1.4.2 Pre-Erythrocytic Vaccine
- 1.4.3 Erythrocytic Vaccine
- 1.4.4 Multi-antigen Vaccine
- 1.5 Market by End User
- 1.5.1 Global Malaria Vaccines Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Community Centers
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Malaria Vaccines Market Size
- 2.1.1 Global Malaria Vaccines Revenue 2014-2025
- 2.1.2 Global Malaria Vaccines Sales 2014-2025
- 2.2 Malaria Vaccines Growth Rate by Regions
- 2.2.1 Global Malaria Vaccines Sales by Regions
- 2.2.2 Global Malaria Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Malaria Vaccines Sales by Manufacturers
- 3.1.1 Malaria Vaccines Sales by Manufacturers
- 3.1.2 Malaria Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Malaria Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Malaria Vaccines Revenue by Manufacturers
- 3.2.1 Malaria Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Malaria Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Malaria Vaccines Price by Manufacturers
- 3.4 Malaria Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Malaria Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Malaria Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Malaria Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Malaria Vaccines Sales by Product
- 4.2 Global Malaria Vaccines Revenue by Product
- 4.3 Malaria Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Malaria Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Malaria Vaccines by Countries
- 6.1.1 North America Malaria Vaccines Sales by Countries
- 6.1.2 North America Malaria Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Malaria Vaccines by Product
- 6.3 North America Malaria Vaccines by End User
7 Europe
- 7.1 Europe Malaria Vaccines by Countries
- 7.1.1 Europe Malaria Vaccines Sales by Countries
- 7.1.2 Europe Malaria Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Malaria Vaccines by Product
- 7.3 Europe Malaria Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Malaria Vaccines by Countries
- 8.1.1 Asia Pacific Malaria Vaccines Sales by Countries
- 8.1.2 Asia Pacific Malaria Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Malaria Vaccines by Product
- 8.3 Asia Pacific Malaria Vaccines by End User
9 Central & South America
- 9.1 Central & South America Malaria Vaccines by Countries
- 9.1.1 Central & South America Malaria Vaccines Sales by Countries
- 9.1.2 Central & South America Malaria Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Malaria Vaccines by Product
- 9.3 Central & South America Malaria Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Malaria Vaccines by Countries
- 10.1.1 Middle East and Africa Malaria Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Malaria Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Malaria Vaccines by Product
- 10.3 Middle East and Africa Malaria Vaccines by End User
11 Company Profiles
- 11.1 GlaxoSmithKline plc
- 11.1.1 GlaxoSmithKline plc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline plc Malaria Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline plc Malaria Vaccines Products Offered
- 11.1.5 GlaxoSmithKline plc Recent Development
- 11.2 Sanaria Inc
- 11.2.1 Sanaria Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanaria Inc Malaria Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanaria Inc Malaria Vaccines Products Offered
- 11.2.5 Sanaria Inc Recent Development
- 11.3 Nobelpharma Co
- 11.3.1 Nobelpharma Co Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Nobelpharma Co Malaria Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Nobelpharma Co Malaria Vaccines Products Offered
- 11.3.5 Nobelpharma Co Recent Development
- 11.4 Sumaya Biotech
- 11.4.1 Sumaya Biotech Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sumaya Biotech Malaria Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sumaya Biotech Malaria Vaccines Products Offered
- 11.4.5 Sumaya Biotech Recent Development
- 11.5 GenVec
- 11.5.1 GenVec Company Details
- 11.5.2 Company Business Overview
- 11.5.3 GenVec Malaria Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 GenVec Malaria Vaccines Products Offered
- 11.5.5 GenVec Recent Development
12 Future Forecast
- 12.1 Malaria Vaccines Market Forecast by Regions
- 12.1.1 Global Malaria Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Malaria Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Malaria Vaccines Market Forecast by Product
- 12.2.1 Global Malaria Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Malaria Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Malaria Vaccines Market Forecast by End User
- 12.4 North America Malaria Vaccines Forecast
- 12.5 Europe Malaria Vaccines Forecast
- 12.6 Asia Pacific Malaria Vaccines Forecast
- 12.7 Central & South America Malaria Vaccines Forecast
- 12.8 Middle East and Africa Malaria Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Malaria Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Malaria Vaccines . Industry analysis & Market Report on Malaria Vaccines is a syndicated market report, published as Global Malaria Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Malaria Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
